Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gordon C Jayson

Showing results (21-30 of 126) with videos related to

Pageof 13
Sort By:
Expert Review of Anticancer Therapy|December 22, 2007
Development of antiangiogenic agents for ovarian cancerFiona J Collinson, Geoff D Hall, Timothy J Perren, et al.
Angiogenesis|October 2, 2014
Segregation of late outgrowth endothelial cells into functional endothelial CD34- and progenitor-like CD34+ cell populationsCristina Ferreras, Claire L Cole, Katharina Urban, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 19, 2007
Imaging tumor vascular heterogeneity and angiogenesis using dynamic contrast-enhanced magnetic resonance imagingAlan Jackson, James P B O'Connor, Geoff J M Parker, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 2004
Doctor, does this mean I'm going to starve to death?Melissa K Whitworth, Andrea Whitfield, Søren Holm, et al.
Chemical Science|August 10, 2018
Making the longest sugars: a chemical synthesis of heparin-related [4] <sub><i>n</i></sub> oligosaccharides from 16-mer to 40-merSteen U Hansen, Gavin J Miller, Matthew J Cliff, et al.
Current Oncology Reports|June 5, 2020
First-Line Management of Advanced High-Grade Serous Ovarian CancerReem D Mahmood, Robert D Morgan, Richard J Edmondson, et al.
Nature Reviews. Clinical Oncology|February 15, 2012
Dynamic contrast-enhanced MRI in clinical trials of antivascular therapiesJames P B O'Connor, Alan Jackson, Geoff J M Parker, et al.
Future Oncology (London, England)|January 19, 2017
Malignant bowel obstruction in advanced ovarian cancerEmma Dean, Leila Khoja, Andrew Clamp, et al.
Cancer Chemotherapy and Pharmacology|February 22, 2018
PARP inhibitors in platinum-sensitive high-grade serous ovarian cancerRobert D Morgan, Andrew R Clamp, D Gareth R Evans, et al.
Cancer Research|June 3, 2004
Hypoxia increases heparanase-dependent tumor cell invasion, which can be inhibited by antiheparanase antibodiesXiaotong He, Paul E C Brenchley, Gordon C Jayson, et al.
Pageof 13

Showing results (21-30 of 126) with videos related to

Sort By:
Pageof 13
Expert Review of Anticancer Therapy|December 22, 2007
Development of antiangiogenic agents for ovarian cancerFiona J Collinson, Geoff D Hall, Timothy J Perren, et al.
Angiogenesis|October 2, 2014
Segregation of late outgrowth endothelial cells into functional endothelial CD34- and progenitor-like CD34+ cell populationsCristina Ferreras, Claire L Cole, Katharina Urban, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 19, 2007
Imaging tumor vascular heterogeneity and angiogenesis using dynamic contrast-enhanced magnetic resonance imagingAlan Jackson, James P B O'Connor, Geoff J M Parker, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 2004
Doctor, does this mean I'm going to starve to death?Melissa K Whitworth, Andrea Whitfield, Søren Holm, et al.
Chemical Science|August 10, 2018
Making the longest sugars: a chemical synthesis of heparin-related [4] <sub><i>n</i></sub> oligosaccharides from 16-mer to 40-merSteen U Hansen, Gavin J Miller, Matthew J Cliff, et al.
Current Oncology Reports|June 5, 2020
First-Line Management of Advanced High-Grade Serous Ovarian CancerReem D Mahmood, Robert D Morgan, Richard J Edmondson, et al.
Nature Reviews. Clinical Oncology|February 15, 2012
Dynamic contrast-enhanced MRI in clinical trials of antivascular therapiesJames P B O'Connor, Alan Jackson, Geoff J M Parker, et al.
Future Oncology (London, England)|January 19, 2017
Malignant bowel obstruction in advanced ovarian cancerEmma Dean, Leila Khoja, Andrew Clamp, et al.
Cancer Chemotherapy and Pharmacology|February 22, 2018
PARP inhibitors in platinum-sensitive high-grade serous ovarian cancerRobert D Morgan, Andrew R Clamp, D Gareth R Evans, et al.
Cancer Research|June 3, 2004
Hypoxia increases heparanase-dependent tumor cell invasion, which can be inhibited by antiheparanase antibodiesXiaotong He, Paul E C Brenchley, Gordon C Jayson, et al.
Pageof 13